Company / Inventory per Share
Regeneron Pharmaceuticals Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$28.15
FY2025
5-year range
$17.03 / $28.15
FY2021-FY2025
Trend
+3.5%
vs FY2024
Sector context
#2 of 105
Health Care
What the data says
Among 105 Health Care companies, Regeneron Pharmaceuticals is in the top 2% for inventory per share. Inventory per Share has increased for 9 consecutive years, from $3.52 in FY2016 to $28.15 in FY2025.
Based on SEC 10-K filings.
28.15 in FY2025 with a 5-year CAGR of +11.0%. Ranks 2nd among 105 companies in Health Care.
Improved from $23.00 to $28.15 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +10.5%
- 5-Year CAGR
- +11.0%
- 10-Year CAGR
- -
Sector benchmark
-8.7% below sector average
Key checks
Key Insights
- Regeneron Pharmaceuticals's inventory per share has grown for 9 consecutive years.
- In FY2025, inventory per share increased 3.5% year-over-year.
- Ranks #2 out of 105 companies in the Health Care sector.
- Lowest inventory per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.15 | +3.5% |
| FY2024 | $27.20 | +18.3% |
| FY2023 | $23.00 | +10.2% |
| FY2022 | $20.87 | +22.6% |
| FY2021 | $17.03 | +2.0% |
| FY2020 | $16.70 | +36.7% |
| FY2019 | $12.21 | +23.4% |
| FY2018 | $9.90 | +57.1% |
| FY2017 | $6.30 | +79.0% |
| FY2016 | $3.52 | +64.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026